1.A study of relationship between hypertension and hyperlipidemia in the health screening center.
Yong Chul KIM ; Im Yu KIM ; Youn Sug CHOI ; H cheol SHIN ; Eun Sook PARK
Journal of the Korean Academy of Family Medicine 1992;13(5):410-419
No abstract available.
Hyperlipidemias*
;
Hypertension*
;
Mass Screening*
2.Replacement of the aortic root with a pulmonary autograft; short term results from 8 patients.
Eun Sug SHIN ; Suk Keun HONG ; Hweung Kon HWANG
Korean Journal of Medicine 2001;60(4):368-372
BACKGROUND: Ross procedure is the pulmonary valve autograft in the aortic valve disease, and its use trends to increase after introduced by Ross in 1967, firstly. The most important point is that it is a permanent valve replacement. It is to be ideal method to the young patient because the graft is a viable tissue to be able to grow, and hemodynamically, most similar to the normal aortic valve, and doesn't need to do anticoagulation therapy due to not having the thromboembolism, but not popular because it has a lot of technical problem and doesn't have the long-term follow-up METHODS: The patients were 8 admitted between October 1997 and October 1998, the age from 15 to 39 ; 6 males and 2 females. The causes of disease were 4 patients of rheumatic disease, 1 of a infective endocarditis with the aortic annular abscess,1 of recurred severe aortic insufficiency 2 years after replacement. Two patients used the homograft and 6 patients switched a diseased aortic valve with the pulmonary autograft. RESULTS: There were no death and the preoperative dyspnea nearly disappeared (NYHA FC III-IV -> I-II). The diastolic diameter of left ventricle decreased significantly when we compared to the previous echocardiography 1 month after the operation, and we observed the mild aortic valve insufficiency in 3 patients, severe in 4, mild pulmonary valve insufficiency in 4, severe in 1, and mild pulmonary valve stenosis in 4. CONCLUSION: The operative death rate of Ross procedure in the aortic valve disease was not higher than the artificial valve replacement. Therefore, if we find the appropriate indication of operation, we can expect better results and think that we should have the long-term follow-up furthermore.
Allografts
;
Aortic Valve
;
Aortic Valve Insufficiency
;
Autografts*
;
Dyspnea
;
Echocardiography
;
Endocarditis
;
Female
;
Follow-Up Studies
;
Heart Ventricles
;
Humans
;
Male
;
Mortality
;
Pulmonary Valve
;
Pulmonary Valve Insufficiency
;
Pulmonary Valve Stenosis
;
Rheumatic Diseases
;
Thromboembolism
;
Transplantation, Autologous
;
Transplants
3.Identification of Differentially Expressed Genes Using RNA Fingerprinting in Cell after DNA Damage.
Jung Young LEE ; Min Sun SHIN ; Seung Myung DONG ; Eun Young NA ; Su Young KIM ; Sug Hyung LEE ; Won Sang PARK ; Nam Jin YOO
Korean Journal of Pathology 1998;32(5):321-327
RNA fingerprinting using on arbitrary primed polymerase chain reaction (RAP-PCR) was carried out to identify differentially expressed genes in HL-60 cell after treatment of methylmethane sulfonate (MMS). Twenty differentially expressed PCR products were cloned and analyzed. We have successfully obtained eight partial cDNA sequences by TA cloning method. Among these, six cDNAs were up-regulated and two cDNAs were down-regulated after the MMS treatment. Of these six up-regulated cDNAs, 3 cDNAs were equivalent to known genes in the GenBank/EMBL databases with 98~100% homology searched by BLAST program: genomic DNA fragment containing CpGg island (clone 26h8), Human Rev interacting protein-1 (RIP-1), and human zinc finger protein-4 (HZF4). The sequences of the three remaining cDNA were entirely new genes, but we didn't try to identify a full cDNA sequence. Two clones called KIAA0060 and KIAA0065, were down-regulated in HL-60 cells after the MMS treatment. These findings suggest that the RNA fingerprinting method using RAP-PCR is an effective method which can identify and separate the differentially expressed cDNAs and that the isolated cDNAs might involve in regulation mechanism of apoptosis and/or cell cycle delay, especially a p53-independent pathway, in the cells after DNA damage. But the nature of cDNAs that we have isolated remains to be elucidated.
Apoptosis
;
Cell Cycle
;
Clone Cells
;
Cloning, Organism
;
Dermatoglyphics*
;
DNA Damage*
;
DNA*
;
DNA, Complementary
;
HL-60 Cells
;
Humans
;
Methyl Methanesulfonate
;
Polymerase Chain Reaction
;
RNA*
;
Zinc Fingers
4.Identification of Zinc Finger Genes that are Differentially Expressed upon Apoptosis of Ramos B Cells.
Min Sun SHIN ; Su Young KIM ; Seung Myung DONG ; Eun Young NA ; Sug Hyung LEE ; Won Sang PARK ; Jung Young LEE ; Nam Jin YOO
Korean Journal of Pathology 1998;32(12):1043-1048
Typical programmed cell death requires de novo macromolecular synthesis and shares common morphological changes referred to as apoptosis. To elucidate the molecular mechanism of apoptosis, we isolated 13 cDNA clones of zinc finger genes that are differentially expressed in calcium ionophore-induced apoptosis of Ramos human B cell by 'targeted RNA fingerprinting' protocol (Stone & Wharton, 1993). According to DNA sequence analysis of the 13 cDNA clones, three clones are identical with ZNF7, ZNF143 and MTB-Zf, respectively, and 8 out of the other 10 clones showed partial homology to known zinc finger genes. Differential expression was confirmed in the three known zinc finger genes by ribonuclease protection assay. ZNF7 and ZNF143 are up-regulated after induction of apoptosis, and, in contrast, MTB-Zf is down-regulated. According to the previous reports on these three genes, all of the three genes have been suspected to be tumor suppressor genes, but their functions have not been identified yet. Taken together, our results suggest that many of the novel and known zinc finger genes might play important roles in regulation of apoptosis and that these findings also provide clues as to the functions of the three putative tumor suppressor genes, ZNF7, ZNF143 and MTB-Zf in terms of apoptosis. In addition, the isolation of zinc finger genes by targeted RNA fingerprinting could be a straightforward approach for the identification of novel candidate genes associated with apoptosis.
Apoptosis*
;
B-Lymphocytes*
;
Calcium
;
Cell Death
;
Clone Cells
;
Dermatoglyphics
;
DNA, Complementary
;
Genes, Tumor Suppressor
;
Humans
;
Ribonucleases
;
RNA
;
Sequence Analysis, DNA
;
Zinc Fingers*
;
Zinc*
5.The Role of gadd and p53 Genes in Apoptosis and Cell Cycle Delay by Genotoxic Agents.
Jung Young LEE ; Jung Duk LEE ; Seung Myung DONG ; Eun Young NA ; Min Sun SHIN ; Su Young KIM ; Sug Hyung LEE ; Won Sang PARK ; Nam Jin YOO
Korean Journal of Pathology 1998;32(4):239-247
The aim of this study was to investigate the relationships between the gadd genes expression and an apoptosis induction in two different growing cell types after treatments with cisplatin and methylmethan sulfonate (MMS). We have examined the kinetics and specificity of gadd45 and gadd153 expression following cisplatin and MMS treatments to HL-60 cells and primary cultured human kidney (HKN) cells. We have also determined an induction time of apoptosis by DNA fragmentation analysis and the presence of the cell cycle arrest by a flow cytometric measurement. The results were as follows. In non-adherent HL-60 cells, a typical ladder pattern was observed within 4 hours after treatments of 20 micrometer of cisplatin and 100 microgram/ml of MMS. At the same time while adherent HKN cells failed to exhibit a ladder pattern at even higher doses of genotoxic agents. Since HL-60 cells do not have p53 gene, these findings suggest the presence of a p53-independent apoptotic pathway. The increasing patterns of the mRNA levels of gadd45 and gadd153 varied with the type of genotoxic agents. In the case of MMS treatment, the induction was rapid and transient, regardless of the cell types. The mRNA level peaked at 4 hours after MMS treatment and markedly decreased after 12 hours. On the other hand, cisplatin-induced transcriptions of gadd45 and gadd153 continued to increase for at least 24 hours and reached a peak level at 48 hours after cisplatin treatment, regardless of the cell types. HL-60 cells revealed G2 arrest following 24 hours after cisplatin and MMS treatments. These findings suggest that the regulation mechanism of apoptosis between adherent and non-adherent cells, might be different and that gadd45 and gadd153 might have an important role in DNA repair rather than apoptosis. Also, the findings suggest that an expression pattern of gadd45 and gadd153 might be different according to the type of genotoxic agents.
Apoptosis*
;
Cell Cycle Checkpoints
;
Cell Cycle*
;
Cisplatin
;
DNA Damage
;
DNA Fragmentation
;
DNA Repair
;
Genes, p53*
;
Hand
;
HL-60 Cells
;
Humans
;
Kidney
;
Kinetics
;
RNA, Messenger
;
Sensitivity and Specificity
6.Left Main Coronary Artery Dissection, Tricuspid Insufficiency, Mitral Insufficiency and Pericardial Rupture Detected 1 Year Following a Blunt Chest Trauma.
Choon Ho HAN ; Seung Mook JUNG ; Joe Sung KIM ; Rak Kyeong CHOI ; Eun Sug SHIN ; Hun Sik PARK ; Hweung Kon HWANG
Korean Circulation Journal 2000;30(10):1295-1299
Coronary artery and valvular injuries after blunt chest trauma are an unusual condition. This diagnosis is very difficult to estabilish, but prompt diagnosis and proper management are important in life saving. We report one patient who develop left main coronary artery dissection, tricuspid insufficiency, mitral insufficiency and pericardial rupture following blunt chest trauma. One year ago, he had suffered a frontal impact in a traffic accident and recieved anti-tuberculosis medication for 10 months for chest discomfort. The correct diagnosis was confirmed noninvasively by transesophageal echocardiography and the patient was treated left main coronary artery dissection flap removal, mitral valve replacement, tricuspid valvuloplasty and repair of ruptured pericardium. The postoperative course was uneventful and the patient was fully recovered.
Accidents, Traffic
;
Coronary Vessels*
;
Diagnosis
;
Echocardiography, Transesophageal
;
Humans
;
Mitral Valve
;
Mitral Valve Insufficiency*
;
Pericardium
;
Rupture*
;
Thorax*
7.A Prospective Study of the Effect of Calcitriol Treatment according to Administration Route in CAPD Patients.
In Hee LEE ; Shin Wook KANG ; Hyun Jin NOH ; Sug Kyun SHIN ; Eun Kyung KIM ; Kyu Hun CHOI ; Sung Kyu HA ; Hyung Sik YOO ; Ho Yung LEE ; Dae Suk HAN
Korean Journal of Nephrology 1999;18(1):148-158
To determine the optimal administration route of calcitriol in CAPD patients with secondary hyperparathyroidism, we conducted a prospective study on 33 patients who performed CAPD for more than 6 months an d whose intact parathyroid hormone(iPTH) level was higher than 250pg/mL. The patients were randomized into 3 groups:IP(n=11); 1.0 microgram of calcitriol once daily via intraperitoneal route by overnight retention with dialysate, SC(n=11); 1.0 microgram of calcitriol three times a week via subcutaneous route, and PO (n=11); 1.0 microgram of calcitriol three times a week by ingestion. 11 out of 33 patients(6 in IP, 4 in SC, and 1 in PO) dropped out during the 6-months study period, and 5 among the 6 patients in IP were due to recurrent peritonitis. Biochemical data including calcium, phosphorus, iPTH, alkaline phosphatase, bone-specific alkaline phosphatase, osteocalcin and 1,25(OH)2D3 were measured regularly, and the data of 22 patients who had completed the 6-months study were analyzed. There was a statistically significant decrease in iPTH level(pg/mL) in the three groups after 6-months calcitriol therapy(IP; 812.0+/-276.7 vs. 354.7+/-129.4, PO; 571.8+/-330.7 vs. 159.6+/-192.3, SC; 786.1+/-535.0 vs. 551.8+/-729.9, respectively, P<0.05), but there were no differences in the percentage of decrease in iPTH from baseline values among the three groups. Alkaline phosphatase, bone- specific alkaline phosphatase and osteocalcin also decreased significantly in all three groups(IP; 50.1+/-14.6, 33.5+/-11.6, 52.3+/-10.9% of baseline value; SC; 80.9+/-14.8, 67.4+/-20.80, 54.4+/-11.1% of baseline value; PO; 48.8+/-24.4, 36.6+/-23.5, 54.2+/-11.6% of baseline value, respectively, P<0.05), but they were not different with each other. Among 22 patients who completed the 6-months study, hypercalcemia(Ca>=10.5 mg/dL) occurred in 7 patients(31.8%). IP(2/5, 40%) and SC groups(5/7, 71.4%) had significantly higher incidence of hypercalcemia than PO group(0/10, 0%) (P<0.05). IP group(2/5, 40%) also experienced significantly higher incidence of hyperphosphatemia than SC(1/7, 14.3%) and PO groups(1/10, 10%). Peritonitis occurred significantly more in IP than in SC and PO groups(P<0.05). In conclusion, calcitriol treatment resulted in a significant decrement in iPTH levels in CAPD patients and no significant differences were noted in the iPTH-suppressive effect of calcitriol according to the administration route. Because of higher incidence of peritonitis and hypercalcemia in IP and SQ groups, oral ingestion may be the most optimal route for calcitriol treatment in CAPD patients with secondary hyperparathyroidism.
Alkaline Phosphatase
;
Calcitriol*
;
Calcium
;
Eating
;
Humans
;
Hypercalcemia
;
Hyperparathyroidism, Secondary
;
Hyperphosphatemia
;
Incidence
;
Osteocalcin
;
Peritoneal Dialysis, Continuous Ambulatory*
;
Peritonitis
;
Phosphorus
;
Prospective Studies*
8.Two Cases of Falciparum Malaria with Acute Respiratory Distress Syndrome.
Joo Hun PARK ; Eun Sug SHIN ; Jun Hee WOO ; Yeun Ok KIM ; In Gyu BAE ; Jae Jeong JANG ; Hyun Sook CHI ; Youn Suck KOH
Tuberculosis and Respiratory Diseases 1998;45(4):888-895
Malaria is one of the most common infectious diseases in the world. Plasmodium falciparum accounting for nearly all malaria mortality, kills an estimated 1 to 2 million persons yearly and has several features thai make it deadlist of malarias. While cerebral malaria is the most common presentation of severe disease, acute lung injury associated with malaria is uncommon but serious and fatal complication. We report two cases of severe malaria with ARDS and multi-organ failure. All two patients traveled to foreign countries, Kenya, Papua New Guinea where choroquine-resistant malaria is distributed. The first case, which developed cerebral malaria hypoglycemia, multi-organ failure, and ARDS, treated with quinine and mechanical ventilator, but expired due to oxygenation failure. Autopsy showed acute necrotizing infiltration, diffuse eosinophilic fibrinoid deposits along the alveolar space, and alveolar macrophage with malaria pigment The second case also developed multi-organ failure, followed by ARDS, and was treated with quinine, exchange transfusion, plasmapheresis, and mechanical ventilator. He recovered with residual restrictive lung change after treatment.
Acute Disease
;
Asian Continental Ancestry Group
;
Autopsy
;
Communicable Diseases
;
Eosinophils
;
Humans
;
Hypoglycemia
;
Kenya
;
Lung
;
Lung Injury
;
Macrophages, Alveolar
;
Malaria*
;
Malaria, Cerebral
;
Mortality
;
Oxygen
;
Papua New Guinea
;
Plasmapheresis
;
Plasmodium falciparum
;
Quinine
;
Respiratory Distress Syndrome, Adult*
;
Ventilators, Mechanical
9.Successful Treatment of Vancomycin-Resistant Enterococcal Peritonitis with linezolid in a Patient on CAPD.
Dong Eun YOO ; Min Kyeung KIM ; Ae Jung HUH ; Young Ah KIM ; Ea Wha KANG ; Tae Hyun YOO ; Sug Kyun SHIN
Korean Journal of Nephrology 2007;26(2):289-293
Peritonitis is one of the major complications of CAPD (continuous ambulatory peritoneal dialysis). Among its causative organisms, vancomycin-resistant enterococcus (VRE) is rare, but serious causative organism, because it is refractory to antibiotics commonly used for CAPD peritonitis. Some drugs such as linezolid and dalfopristin have been introduced for VRE infections nowadays, but reports about usefulness of those drugs in VRE peritonitis are rare. We experienced a case of CAPD peritonitis caused by VRE, which was treated successfully with removal of CAPD catheter and use of linezolid. We report our experience with review of the literature.
Anti-Bacterial Agents
;
Catheters
;
Enterococcus
;
Humans
;
Peritoneal Dialysis, Continuous Ambulatory*
;
Peritonitis*
;
Linezolid
10.A Personalized and Learning Approach for Identifying Drugs with Adverse Events.
Sug Kyun SHIN ; Ho HUR ; Eun Kyung CHEON ; Ock Hee OH ; Jeong Seon LEE ; Woo Jin KO ; Beom Seok KIM ; YoungOk KWON
Yonsei Medical Journal 2017;58(6):1229-1236
PURPOSE: Adverse drug events (ADEs) are associated with high health and financial costs and have increased as more elderly patients treated with multiple medications emerge in an aging society. It has thus become challenging for physicians to identify drugs causing adverse events. This study proposes a novel approach that can improve clinical decision making with recommendations on ADE causative drugs based on patient information, drug information, and previous ADE cases. MATERIALS AND METHODS: We introduce a personalized and learning approach for detecting drugs with a specific adverse event, where recommendations tailored to each patient are generated using data mining techniques. Recommendations could be improved by learning the associations of patients and ADEs as more ADE cases are accumulated through iterations. After consulting the system-generated recommendations, a physician can alter prescriptions accordingly and report feedback, enabling the system to evolve with actual causal relationships. RESULTS: A prototype system is developed using ADE cases reported over 1.5 years and recommendations obtained from decision tree analysis are validated by physicians. Two representative cases demonstrate that the personalized recommendations could contribute to more prompt and accurate responses to ADEs. CONCLUSION: The current system where the information of individual drugs exists but is not organized in such a way that facilitates the extraction of relevant information together can be complemented with the proposed approach to enhance the treatment of patients with ADEs. Our illustrative results show the promise of the proposed system and further studies are expected to validate its performance with quantitative measures.
Aged
;
Aging
;
Clinical Decision-Making
;
Complement System Proteins
;
Data Mining
;
Decision Trees
;
Drug-Related Side Effects and Adverse Reactions
;
Humans
;
Learning*
;
Prescriptions